돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 486생성일: 2026년 10월 24일

Morpholine → methyl 2-methyl-1-{[2-methyl-3-(trifluoromethyl)phenyl]methyl}-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylate

https://huagongshe.com/ko/reaction/486

반응식

참여 물질

역할이름HCID투입량
반응물MorpholineHCID 8083—
반응물HCID 178418216HCID 178418216—
시약Potassium tert-butoxideHCID 23665647—
촉매TributylphosphineHCID 13831—
촉매Palladium (II) acetateHCID 4144353—
용매1,4-DioxaneHCID 31275—
생성물methyl 2-methyl-1-{[2-methyl-3-(trifluoromethyl)phenyl]methyl}-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylateHCID 569598280%

반응 단계

methyl 6-bromo-2-methyl-1-(2-methyl-3-(trifluoromethyl)benzyl)-1H-benzo[d]imidazole-4-carboxylate (441 mg, 1.00 mmol) was taken up with morpholine (435 µl, 5.00 mmol), potassium tert-butoxide (449 mg, 4.00 mmol), tri-n-butylphosphine (49.3 µl, 0.2 mmol) and palladium(II) acetate (22.44 mg, 0.10 mmol) in dioxane (10ml) and heated for 18 hrs at 100°C. The reaction profile showed no required product and only dimer adduct to be present. the reaction was therefore abandoned.

출처 및 근거

출처 데이터셋750 AstraZeneca ELN dataset
ORD IDord-f93da8755d504800bf04ba573750bf86
출처 메모750 AstraZeneca ELN dataset